Page last updated: 2024-08-18

pyrazolanthrone and Osteogenic Sarcoma

pyrazolanthrone has been researched along with Osteogenic Sarcoma in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Cai, X; Zhu, S1
Ji, G; Li, Z; Lin, B; Liu, W; Wang, S; Wei, G; Xue, X; Yu, N1
Gu, R; Li, Q; Liu, Y; Lu, P; Wu, X; Yan, L; Yu, X; Zhang, Y; Zhu, D; Zou, J1
Hou, M; Shi, Q; Wang, H; Weng, Y; Yan, S; Yao, J; Zuo, G1
Du, X; Huang, Q; Li, K; Ou, Y; Tao, Y; Tu, P; Yin, H1
Chen, F; James, AW; Soo, C; Soofer, DE; Ting, K; Walder, B; Zhang, X1
Fromigué, O; Marie, PJ; Modrowski, D; Orosco, A; Thévenard, J1

Other Studies

7 other study(ies) available for pyrazolanthrone and Osteogenic Sarcoma

ArticleYear
Prognosis-related VDAC1 regulates the proliferation and apoptosis of osteosarcoma cells via the MAPK signaling pathway.
    Genomics, 2023, Volume: 115, Issue:3

    Topics: Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Osteosarcoma; Prognosis; Signal Transduction; Voltage-Dependent Anion Channel 1

2023
Acacetin Induces Apoptosis in Human Osteosarcoma Cells by Modulation of ROS/JNK Activation.
    Drug design, development and therapy, 2020, Volume: 14

    Topics: Anthracenes; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavones; Humans; JNK Mitogen-Activated Protein Kinases; Osteosarcoma; Reactive Oxygen Species

2020
Andrographolide Induces Autophagic Cell Death and Inhibits Invasion and Metastasis of Human Osteosarcoma Cells in An Autophagy-Dependent Manner.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 44, Issue:4

    Topics: Anthracenes; Apoptosis; Autophagy; Beclin-1; Bone Neoplasms; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Diterpenes; Humans; JNK Mitogen-Activated Protein Kinases; Oligopeptides; Osteosarcoma; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA Interference; RNA, Small Interfering; Signal Transduction; TOR Serine-Threonine Kinases

2017
NOV inhibits proliferation while promoting apoptosis and migration in osteosarcoma cell lines through p38/MAPK and JNK/MAPK pathways.
    Oncology reports, 2015, Volume: 34, Issue:4

    Topics: Anthracenes; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Nephroblastoma Overexpressed Protein; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines

2015
Aloe-emodin-mediated photodynamic therapy induces autophagy and apoptosis in human osteosarcoma cell line MG‑63 through the ROS/JNK signaling pathway.
    Oncology reports, 2016, Volume: 35, Issue:6

    Topics: Acetylcysteine; Anthracenes; Anthraquinones; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Osteosarcoma; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species

2016
NELL-1-dependent mineralisation of Saos-2 human osteosarcoma cells is mediated via c-Jun N-terminal kinase pathway activation.
    International orthopaedics, 2012, Volume: 36, Issue:10

    Topics: Anthracenes; Bone Neoplasms; Calcification, Physiologic; Calcium Phosphates; Calcium Signaling; Calcium-Binding Proteins; Cell Differentiation; Cell Line, Tumor; Enzyme Activation; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Nerve Tissue Proteins; Osteocytes; Osteosarcoma; Recombinant Proteins

2012
Syndecan-2 overexpression induces osteosarcoma cell apoptosis: Implication of syndecan-2 cytoplasmic domain and JNK signaling.
    Bone, 2005, Volume: 37, Issue:2

    Topics: Anthracenes; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Membrane Glycoproteins; Mutation; Osteoblasts; Osteosarcoma; Phosphorylation; Protein Structure, Tertiary; Proteoglycans; Signal Transduction; Syndecan-2

2005